Vaccine Administration Rates
Conditions
Brief summary
The purpose of the Gardasil study is to increase the rates of Gardasil vaccination at a maternal fetal Care Center. This will be done by reminding patients via text to come for follow up vaccine appointments.
Detailed description
Patients will be screened in center for history of Gardasil vaccination. If the patient has not received the vaccination series they will be counseled/educated (standard of care \[SOC }) and offered the vaccine series. If the patient agrees to the vaccination, they will then be offered participation in this study, (consent will be reviewed and signed) and they will receive the first vaccination at this visit, administered according to standard protocol. The patient will then be scheduled for two follow up vaccination appointments. The second vaccination will be given 2 months after the first vaccine and the third will be given 4 months after the second vaccination in accordance with the Gardasil vaccine guidelines. -SOC The patients will receive a total of two texts during the study entirety. The two texts will be appointment reminders for the second and third vaccination, sent 1 week prior to the next appointment. This is study related. Data collection Data will be collected using a data collection sheet. The investigators will record date of first vaccine administration and adherence to follow up.vaccinations.
Interventions
BEHAVIORALAppointment reminders
The purpose of the Gardasil study is to increase the rates of Gardasil vaccination in the Maternal Fetal Care Center. This will be done by reminding patients via text to come for their follow up vaccine appointments.
Sponsors
St. Louis University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
9 Years to 26 Years
Healthy volunteers
No
Inclusion criteria
* Patient receiving gynecological or postpartum care at the Maternal Fetal Care Center * Females age 9-26 years per manufacturer's recommendation * Having a cell phone that will allow texting * Willing to accept any texting charges that may occur for receiving the reminder text.
Exclusion criteria
* Allergy to HPV-4 or HPV-9 vaccine * Prior completion of the HPV-4/9 series, * Pregnancy * Patients older than 26 years old
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Increase HPV-9 vaccine administration rates | through study completion, an average of 1 year | The text reminder messages will increase HPV-9 vaccine administration rates |
Countries
United States
Outcome results
None listed